Æterna Zentaris CEO to Take Part in Panel Discussion on Cancer Therapy at
Upcoming RBC Capital Markets Healthcare Conference in New York on March 3

QUÉBEC CITY, Feb. 23 /CNW Telbec/ - Æterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), (the "Company"), a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will take part in a panel discussion titled, "Cancer: Improving Treatment through Combination Therapy" at the RBC Capital Markets Healthcare Conference on Wednesday, March 3, 2010, from 8:00 am to 8:55 am (eastern) in the Holmes I Room of The New York Palace Hotel in New York City.

A live audio webcast of the panel discussion will be available in the Investors section of the Company's website at www.aezsinc.com. A replay of the webcast will also be available on its website for a period of 30 days.

About Æterna Zentaris Inc.

Æterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.

SOURCE Aeterna Zentaris Inc.

For further information: For further information: Investor Relations: Ginette Vallières, Investor Relations Coordinator, (418) 652-8525 ext. 265, gvallieres@aezsinc.com; Media Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext. 406, pburroughs@aezsinc.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890